793 related articles for article (PubMed ID: 33602090)
1. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
3. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.
Bahadur S; Sachan N; Harwansh RK; Deshmukh R
Curr Pharm Des; 2020; 26(12):1331-1344. PubMed ID: 32160843
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
Jain D; Rashid MA; Ahmad FJ
Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
[TBL] [Abstract][Full Text] [Related]
7. Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives.
Zakharova L; Gaynanova G; Vasilieva E; Vasileva L; Pavlov R; Kashapov R; Petrov K; Sinyashin O
Curr Med Chem; 2023; 30(33):3743-3774. PubMed ID: 36380443
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer's Disease Management.
Dighe S; Jog S; Momin M; Sawarkar S; Omri A
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258068
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease.
Unnisa A; Greig NH; Kamal MA
Curr Med Chem; 2023; 30(3):255-270. PubMed ID: 35345990
[TBL] [Abstract][Full Text] [Related]
11. Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition.
Gorain B; Rajeswary DC; Pandey M; Kesharwani P; Kumbhar SA; Choudhury H
Curr Pharm Des; 2020; 26(19):2233-2246. PubMed ID: 32167424
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
[TBL] [Abstract][Full Text] [Related]
13. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
15. Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route.
Tripathi S; Gupta U; Ujjwal RR; Yadav AK
J Microencapsul; 2021; 38(7-8):572-593. PubMed ID: 34591731
[TBL] [Abstract][Full Text] [Related]
16. Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients.
Bhattacharya S
Curr Pharm Biotechnol; 2023; 24(9):1108-1121. PubMed ID: 36305141
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology-based delivery of therapeutics through the intranasal pathway and the blood-brain barrier for Alzheimer's disease treatment.
Boyetey MB; Choi Y; Lee HY; Choi J
Biomater Sci; 2024 Apr; 12(8):2007-2018. PubMed ID: 38456516
[No Abstract] [Full Text] [Related]
18. Emerging Nanotechnology for the Treatment of Alzheimer's Disease.
Singh A; Ansari VA; Mahmood T; Ahsan F; Wasim R; Maheshwari S; Shariq M; Parveen S; Shamim A
CNS Neurol Disord Drug Targets; 2024; 23(6):687-696. PubMed ID: 37138478
[TBL] [Abstract][Full Text] [Related]
19. Intranasal drug delivery for treatment of Alzheimer's disease.
Fonseca LC; Lopes JA; Vieira J; Viegas C; Oliveira CS; Hartmann RP; Fonte P
Drug Deliv Transl Res; 2021 Apr; 11(2):411-425. PubMed ID: 33638130
[TBL] [Abstract][Full Text] [Related]
20. Carbon Nano Tubes: Novel Drug Delivery System in Amelioration of Alzheimer's Disease.
Mishra J; Kumar B; Pandey M; Pottoo FH; Fayaz F; Khan FA; Sahoo PK
Comb Chem High Throughput Screen; 2021; 24(10):1528-1543. PubMed ID: 32957874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
